Anthera Pharmaceuticals Inc. (ANTH) OTC MARKETS

- - (-)

Market Cap: $2618

As of 03/14/24 04:00 PM EDT. Market closed.

(ANTH)

Anthera Pharmaceuticals Inc. (ANTH)
OTC MARKETS

-
- (-)

Market Cap: $2618

As of 03/14/24 04:00 PM EDT. Market closed.

Add to Portfolio

anthera pharmaceuticals, inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. anthera has two product candidates, sollpura, in phase 3 development for exocrine pancreatic insufficiency due to cystic fibrosis and blisibimod, in phase 2 development for iga nephropathy. nasdaq: ... read more

anthera pharmaceuticals, inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. anthera has two product candidates, sollpura, in phase 3 development for exocrine pancreatic insufficiency due to cystic fibrosis and blisibimod, in phase 2 development for iga nephropathy. nasdaq: anth read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
25801 Industrial Blvd Ste B, California, Hayward, 94545-2223.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
J. Craig Thompson
Address
25801 Industrial Blvd Ste B, California, Hayward, 94545-2223.
PRICE CHART FOR ANTHERA PHARMACEUTICALS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
-
Days Range
- - -
52 week range
$0 - $0
Volume
0
Avg. Volume (30 days)
2,500
Market Cap
$2618
Dividend Yield
-
P/E
-
Shares Outstanding
26,179,302
Open
-
Previous Close
-
Days Range
- - -
52 week range
$0 - $0
Volume
0
Avg. Volume (30 days)
2,500
Market Cap
$2618
Dividend Yield
-
P/E
-
Shares Outstanding
26,179,302
FINANCIAL STATEMENTS FOR ANTHERA PHARMACEUTICALS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR ANTHERA PHARMACEUTICALS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
THOMPSON JOHN CRAIGPresident & CEOSep 20, 2017 Buy$1.328,55011,28619,848Sep 20, 2017, 07:14 PM
TRUEX PAUL FDirectorSep 07, 2017 Buy$1.345,0006,70016,793Sep 07, 2017, 06:56 PM
THOMPSON JOHN CRAIGPresident & CEOSep 07, 2017 Buy$1.4310,40014,89311,298Sep 07, 2017, 06:56 PM
THOMPSON JOHN CRAIGPresident & CEOSep 07, 2017 Option Exercise$1.4310,40014,89317,590Sep 07, 2017, 02:43 PM
TRUEX PAUL FChief Executive OfficerSep 20, 2016 Option Exercise$2.085,00810,4175,008Sep 22, 2016, 07:29 PM
Mueller BrianDirectorDec 23, 2015 Option Exercise$2.8910,00028,90010,000Dec 24, 2015, 12:35 PM
Hislop ColinChief Medical OfficerNov 13, 2015 Option Exercise$1.6112,50020,12531,647Nov 18, 2015, 06:53 PM
Hislop ColinChief Medical OfficerNov 13, 2015 Sale$5.3112,50066,34119,147Nov 18, 2015, 06:53 PM
ODINK DEBRAChief Technology OfficerOct 12, 2015 Sale$6.151,2057,4117,896Oct 13, 2015, 08:02 PM
TRUEX PAUL FPresident and CEOJun 30, 2014 Option Exercise$3.396992,37014,709Jul 01, 2014, 08:09 PM
TRUEX PAUL FPresident and CEOJun 30, 2014 Option Exercise$2.082,0004,16013,845Jul 01, 2014, 08:09 PM
TRUEX PAUL FPresident and CEOJun 30, 2013 Option Exercise$3.306,25020,62580,190Mar 28, 2014, 09:23 PM
TRUEX PAUL FPresident and CEOMar 25, 2014 Option Exercise$3.308,97429,61411,845Mar 28, 2014, 09:23 PM
LIU MAYChief Accounting OfficerMar 25, 2014 Option Exercise$3.305291,7463,677Mar 27, 2014, 09:57 PM
ODINK DEBRAChief Technology OfficerMar 25, 2014 Option Exercise$3.302,7839,1846,601Mar 27, 2014, 09:57 PM
TRUEX PAUL FPresident and CEOMar 25, 2014 Option Exercise$3.306,25020,625597,787Mar 27, 2014, 09:56 PM
TRUEX PAUL FPresident and CEOMar 25, 2014 Option Exercise$3.307,62225,1539,333Mar 27, 2014, 09:56 PM
ODINK DEBRAChief Technology OfficerJun 30, 2013 Option Exercise$0.492,2481,10275,074Jul 02, 2013, 09:17 PM
LIU MAYChief Accounting OfficerJun 30, 2013 Option Exercise$0.4967533133,655Jul 02, 2013, 09:17 PM
Thompson David E.DirectorJun 24, 2013 Buy$0.53100,00053,000128,201Jun 26, 2013, 05:24 PM
DZIURZYNSKI BOGDANDirectorMay 31, 2013 Buy$0.5910,0005,90010,000Jun 04, 2013, 07:26 PM
ORBIMED ADVISORS LLCDirectorJan 30, 2013 Buy$0.665,700,0003,762,0007,462,000Feb 01, 2013, 08:19 PM
ORBIMED ADVISORS LLCDirectorJan 25, 2013 Buy$0.651,762,0001,142,4811,762,000Jan 29, 2013, 04:54 PM
TRUEX PAUL FPresident and CEOJan 03, 2013 Option Exercise$0.6917,45412,04366,412Jan 08, 2013, 05:29 PM
KILFOIL GEORGINASVP,Product Dev.& Project MgmtJan 03, 2013 Option Exercise$0.692,4101,66330,035Jan 07, 2013, 09:20 PM
ODINK DEBRAChief Technology OfficerJan 03, 2013 Option Exercise$0.693,4092,35231,812Jan 07, 2013, 09:18 PM
Hislop ColinChief Medical OfficerJan 03, 2013 Option Exercise$0.694,5603,14684,959Jan 07, 2013, 09:17 PM
LOWE CHRISTOPHER P.C.F.O. and C.B.O.Jan 03, 2013 Option Exercise$0.698,6605,97541,336Jan 07, 2013, 09:17 PM
KILFOIL GEORGINASVP,Product Dev.& Project MgmtJun 30, 2012 Option Exercise$0.692,0681,42724,601Jul 03, 2012, 07:27 PM
ODINK DEBRAChief Technology OfficerJun 30, 2012 Option Exercise$0.691,8381,26824,821Jul 03, 2012, 07:27 PM
ORBIMED ADVISORS LLCDirectorJun 29, 2012 Sale$0.731,283,300942,0710Jul 03, 2012, 03:19 PM
HENNEY CHRISTOPHER SDirectorJun 29, 2012 Buy$0.75100,00074,930100,000Jul 02, 2012, 05:46 PM
HENNEY CHRISTOPHER SDirectorJun 29, 2012 Buy$0.75100,00074,930202,429Jul 02, 2012, 05:46 PM
TRUEX PAUL FPresident and CEOJun 29, 2012 Buy$0.7620,00015,200645,125Jul 02, 2012, 03:53 PM
ORBIMED ADVISORS LLCDirectorMar 22, 2012 Sale$2.401,306,7003,140,1311,283,300Mar 22, 2012, 06:15 PM
ORBIMED ADVISORS LLCDirectorMar 21, 2012 Sale$2.87125,000358,3122,590,000Mar 22, 2012, 06:15 PM
ORBIMED ADVISORS LLCDirectorMar 20, 2012 Sale$2.90116,800338,6382,715,000Mar 22, 2012, 06:15 PM
ODINK DEBRAChief Technology OfficerMar 01, 2012 Sale$6.572,00013,14026,659Mar 05, 2012, 04:01 PM
Hislop ColinChief Medical OfficerFeb 23, 2012 Option Exercise$0.2640,00010,40079,519Feb 27, 2012, 05:26 PM
TRUEX PAUL FPresident and C.E.O.Feb 15, 2012 Sale$7.8415,000117,600625,125Feb 17, 2012, 05:15 PM
Hislop ColinChief Medical OfficerFeb 03, 2012 Sale$8.2030,000246,00027,967Feb 06, 2012, 08:04 PM
LOWE CHRISTOPHER P.C.F.O. and C.B.O.Feb 01, 2012 Sale$7.6615,000114,90031,151Feb 03, 2012, 04:01 PM
ODINK DEBRAChief Technology OfficerFeb 01, 2012 Sale$7.672,00015,34021,241Feb 03, 2012, 04:01 PM
TRUEX PAUL FPresident and C.E.O.Jan 31, 2012 Option Exercise$0.2620,0005,200640,125Feb 02, 2012, 07:37 PM
HEALY JAMESDirectorJan 28, 2012 Option Exercise$4.1912,00050,28032,443Jan 31, 2012, 05:53 PM
TRUEX PAUL FPresident and Chief ExecutiveJan 17, 2012 Sale$6.7515,000101,250627,125Jan 19, 2012, 05:03 PM
ODINK DEBRAChief Technology OfficerJan 10, 2012 Sale$6.518005,20523,241Jan 12, 2012, 12:58 PM
ODINK DEBRAChief Technology OfficerJan 06, 2012 Sale$6.501,2007,80024,441Jan 10, 2012, 02:27 PM
HEALY JAMESDirectorDec 30, 2011 Sale$6.2225,000155,6253,298,684Jan 03, 2012, 08:31 PM
SOFINNOVA VENTURE PARTNERS VI L P10% OwnerDec 30, 2011 Sale$6.2225,000155,6253,298,684Jan 03, 2012, 08:31 PM
HEALY JAMESDirectorDec 22, 2011 Sale$6.2225,000155,6053,319,314Dec 23, 2011, 06:22 PM
HEALY JAMESDirectorDec 21, 2011 Sale$6.5125,000162,7703,339,944Dec 23, 2011, 06:22 PM
SOFINNOVA VENTURE PARTNERS VI L P10% OwnerDec 22, 2011 Sale$6.2225,000155,6053,319,314Dec 23, 2011, 06:22 PM
SOFINNOVA VENTURE PARTNERS VI L P10% OwnerDec 21, 2011 Sale$6.5125,000162,7703,339,944Dec 23, 2011, 06:22 PM
SOFINNOVA VENTURE PARTNERS VI L P10% OwnerMar 04, 2010 Option Exercise$6.751,253,6358,462,7573,360,574Dec 22, 2011, 06:24 PM
SOFINNOVA VENTURE PARTNERS VI L P10% OwnerMar 04, 2010 Option Exercise$5.53741,2154,097,6982,326,015Dec 22, 2011, 06:24 PM
TRUEX PAUL FPresident and CEODec 15, 2011 Sale$6.3415,00095,065642,125Dec 16, 2011, 09:53 PM
ORBIMED ADVISORS LLCDirectorDec 13, 2011 Sale$6.5016,200105,3002,831,800Dec 13, 2011, 06:37 PM
ORBIMED ADVISORS LLCDirectorDec 09, 2011 Sale$6.7540,000270,0002,848,000Dec 13, 2011, 06:37 PM
ORBIMED ADVISORS LLCDirectorNov 16, 2011 Sale$6.8725,000171,7502,915,000Nov 18, 2011, 05:57 PM
ORBIMED ADVISORS LLCDirectorNov 18, 2011 Sale$6.503,00019,5002,888,000Nov 18, 2011, 05:57 PM
ORBIMED ADVISORS LLCDirectorNov 17, 2011 Sale$6.6724,000160,0802,891,000Nov 18, 2011, 05:57 PM
TRUEX PAUL FPresident and CEONov 15, 2011 Sale$6.9630,000208,704672,125Nov 17, 2011, 04:01 PM
ORBIMED ADVISORS LLCDirectorNov 11, 2011 Sale$7.145,00035,7002,995,000Nov 15, 2011, 06:29 PM
ORBIMED ADVISORS LLCDirectorNov 15, 2011 Sale$6.9350,000346,5002,940,000Nov 15, 2011, 06:29 PM
ORBIMED ADVISORS LLCDirectorNov 14, 2011 Sale$6.955,00034,7502,990,000Nov 15, 2011, 06:29 PM
Hislop ColinChief Medical OfficerNov 08, 2011 Option Exercise$0.2615,0003,90072,967Nov 10, 2011, 05:06 PM
Hislop ColinChief Medical OfficerNov 08, 2011 Sale$6.7415,000101,16357,967Nov 10, 2011, 05:06 PM
LOWE CHRISTOPHER P.Chief Financial Officer & CBONov 03, 2011 Sale$6.8815,000103,23646,151Nov 04, 2011, 08:24 PM
LOWE CHRISTOPHER P.Chief Financial Officer & CBOOct 25, 2011 Sale$7.074,63732,7840Oct 27, 2011, 07:48 PM
TRUEX PAUL FPresident and CEOOct 21, 2011 Sale$6.2523,235145,219649,004Oct 25, 2011, 09:55 PM
TRUEX PAUL FPresident and CEOOct 18, 2011 Sale$6.256,74542,156660,360Oct 20, 2011, 09:28 PM
LOWE CHRISTOPHER P.Chief Financial Officer & CBOAug 08, 2011 Option Exercise$1.3410,00013,40061,151Aug 09, 2011, 06:21 PM
TRUEX PAUL FPresident and CEOAug 08, 2011 Option Exercise$0.2650,00013,00090,512Aug 09, 2011, 06:16 PM
LOWE CHRISTOPHER P.Chief Financial Officer & CBOAug 03, 2011 Sale$6.8814,600100,43251,151Aug 04, 2011, 08:08 PM
LOWE CHRISTOPHER P.Chief Financial Officer & CBOAug 02, 2011 Sale$7.315,00036,5714,937Aug 04, 2011, 08:08 PM
TRUEX PAUL FPresident and CEOJul 15, 2011 Sale$7.9515,000119,258667,125Jul 18, 2011, 05:40 PM
Hislop ColinChief Medical OfficerJul 12, 2011 Option Exercise$0.2615,0003,90057,967Jul 14, 2011, 04:15 PM
VANTAGEPOINT VENTURE ASSOCIATES IV LLC10% OwnerJul 07, 2011 Option Exercise$2.4219,56347,2645,357,528Jul 11, 2011, 05:49 PM
TRUEX PAUL FPresident and CEOJun 30, 2011 Option Exercise$8.1748,500396,24540,512Jul 05, 2011, 06:37 PM
LOWE CHRISTOPHER P.Chief Financial Officer & CBOJun 30, 2011 Option Exercise$8.1723,500191,99565,751Jul 05, 2011, 06:34 PM
KILFOIL GEORGINASVP, Prod. Dev. & Project MngmJun 30, 2011 Option Exercise$8.175,62545,95616,875Jul 05, 2011, 06:31 PM
Hislop ColinChief Medical OfficerJun 30, 2011 Option Exercise$8.1717,500142,97542,967Jul 05, 2011, 06:28 PM
ODINK DEBRAVP, Pharmaceutical R&DJun 30, 2011 Option Exercise$8.173,67029,98425,641Jul 05, 2011, 06:23 PM
Hislop ColinChief Medical OfficerJun 29, 2011 Option Exercise$0.2610,0002,60060,062Jun 30, 2011, 08:06 PM
LOWE CHRISTOPHER P.Chief Financial Officer & CBOJun 21, 2011 Option Exercise$1.3120,00026,20087,645Jun 22, 2011, 08:11 PM
VANTAGEPOINT VENTURE ASSOCIATES IV LLC10% OwnerJun 16, 2011 Sale$8.673,10026,8774,836,202Jun 20, 2011, 05:46 PM
TRUEX PAUL FPresident and CEOJun 15, 2011 Sale$8.3015,000124,539682,125Jun 17, 2011, 07:50 PM
VANTAGEPOINT VENTURE ASSOCIATES IV LLC10% OwnerJun 14, 2011 Sale$8.816996,1584,839,011Jun 15, 2011, 08:21 PM
VANTAGEPOINT VENTURE ASSOCIATES IV LLC10% OwnerJun 13, 2011 Sale$8.801,30011,4404,839,645Jun 15, 2011, 08:21 PM
ORBIMED ADVISORS LLCDirectorJun 10, 2011 Sale$8.1830,000245,4003,000,000Jun 10, 2011, 06:28 PM
ORBIMED ADVISORS LLCDirectorJun 09, 2011 Sale$8.1137,000300,0703,030,000Jun 10, 2011, 06:28 PM
ORBIMED ADVISORS LLCDirectorJun 08, 2011 Sale$8.0233,000264,6603,067,000Jun 10, 2011, 06:28 PM
ORBIMED ADVISORS LLCDirectorMay 18, 2011 Sale$8.0369,334556,7523,139,000Jun 06, 2011, 06:19 AM
ORBIMED ADVISORS LLCDirectorMay 17, 2011 Sale$8.32100,000832,0003,208,334Jun 06, 2011, 06:19 AM
ORBIMED ADVISORS LLCDirectorMay 16, 2011 Sale$7.2012,00086,4003,308,334Jun 06, 2011, 06:19 AM
ORBIMED ADVISORS LLCDirectorMay 11, 2011 Sale$7.2213,00093,8603,320,334Jun 06, 2011, 06:16 AM
ORBIMED ADVISORS LLCDirectorMay 10, 2011 Sale$7.23106,400769,2723,333,334Jun 06, 2011, 06:16 AM
ORBIMED ADVISORS LLCDirectorMay 09, 2011 Sale$7.2610,00072,6003,439,734Jun 06, 2011, 06:16 AM
VANTAGEPOINT VENTURE ASSOCIATES IV LLC10% OwnerMay 26, 2011 Sale$8.604,80041,2804,840,823May 31, 2011, 07:31 PM
ORBIMED ADVISORS LLCDirectorMay 26, 2011 Sale$8.5334,200291,7263,100,000May 27, 2011, 06:58 PM
ORBIMED ADVISORS LLCDirectorMay 25, 2011 Sale$8.654,80041,5203,134,200May 27, 2011, 06:58 PM
VANTAGEPOINT VENTURE ASSOCIATES IV LLC10% OwnerMay 25, 2011 Sale$8.6732,750283,9434,845,172May 25, 2011, 06:42 PM
VANTAGEPOINT VENTURE ASSOCIATES IV LLC10% OwnerMay 24, 2011 Sale$8.4252,196439,4904,874,844May 25, 2011, 06:42 PM
VANTAGEPOINT VENTURE ASSOCIATES IV LLC10% OwnerMay 23, 2011 Sale$8.1826,703218,4314,922,134May 25, 2011, 06:42 PM
VANTAGEPOINT VENTURE ASSOCIATES IV LLC10% OwnerMay 19, 2011 Sale$8.03125,0001,003,7504,946,327May 19, 2011, 06:23 PM
VANTAGEPOINT VENTURE ASSOCIATES IV LLC10% OwnerMay 17, 2011 Sale$8.2913,900115,2315,059,578May 19, 2011, 06:23 PM
TRUEX PAUL FPresident and CEOMay 16, 2011 Sale$7.1615,000107,339692,003May 18, 2011, 07:28 PM
ORBIMED ADVISORS LLCDirectorMay 18, 2011 Sale$8.0369,334556,7523,139,000May 18, 2011, 07:12 PM
ORBIMED ADVISORS LLCDirectorMay 17, 2011 Sale$8.32100,000832,0003,208,334May 18, 2011, 07:12 PM
ORBIMED ADVISORS LLCDirectorMay 16, 2011 Sale$7.2012,00086,4003,308,334May 18, 2011, 07:12 PM
ORBIMED ADVISORS LLCDirectorMay 10, 2011 Sale$7.23106,400769,2723,333,334May 11, 2011, 08:21 PM
ORBIMED ADVISORS LLCDirectorMay 09, 2011 Sale$7.2610,00072,6003,439,734May 11, 2011, 08:21 PM
ORBIMED ADVISORS LLCDirectorMay 11, 2011 Sale$7.2213,00093,8603,320,334May 11, 2011, 08:21 PM
VANTAGEPOINT VENTURE ASSOCIATES IV LLC10% OwnerMay 05, 2011 Sale$7.01387,7002,717,7775,072,171May 05, 2011, 05:36 PM
VANTAGEPOINT VENTURE ASSOCIATES IV LLC10% OwnerMay 04, 2011 Sale$7.00200,0001,400,0005,423,428May 05, 2011, 05:36 PM
VANTAGEPOINT VENTURE ASSOCIATES IV LLC10% OwnerMay 03, 2011 Sale$7.00100,000700,0005,604,628May 05, 2011, 05:36 PM
ODINK DEBRAVP, Pharmaceutical R&DApr 13, 2011 Option Exercise$1.513,3115,00029,311Apr 14, 2011, 08:36 PM
TRUEX PAUL FPresident and CEOApr 13, 2011 Option Exercise$0.2630,0007,800121,122Apr 14, 2011, 08:35 PM
Thompson David E.DirectorJan 03, 2011 Option Exercise$1.3911,55816,06711,558Jan 05, 2011, 08:50 PM
ORBIMED ADVISORS LLC10% OwnerSep 30, 2010 Buy$4.0819,90081,1923,449,734Oct 04, 2010, 08:08 PM
ODINK DEBRAVP, Pharmaceutical R&DSep 24, 2010 Buy$4.201,0004,20026,000Sep 24, 2010, 09:22 PM
LOWE CHRISTOPHER P.CFO & VP of AdministrationSep 24, 2010 Buy$4.185,00020,90062,523Sep 24, 2010, 09:20 PM
Leheny A. RachelDirectorSep 24, 2010 Buy$3.00250,000750,0001,423,896Sep 24, 2010, 09:19 PM
Trias JoaquimSr. VP, Preclinical DevelopmenSep 21, 2010 Option Exercise$1.514,3806,614198,546Sep 23, 2010, 08:44 PM
Hislop ColinSr. VP, Cardiovasc. Prod.Sep 21, 2010 Option Exercise$0.2614,6833,81815,183Sep 23, 2010, 08:40 PM
Hislop ColinSr. VP, Cardiovasc. Prod.Aug 18, 2010 Buy$4.805002,400500Aug 20, 2010, 02:37 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
THOMPSON JOHN CRAIGPresident & CEO09/20/201711,286
TRUEX PAUL FDirector09/07/20176,700
THOMPSON JOHN CRAIGPresident & CEO09/07/201714,893
THOMPSON JOHN CRAIGPresident & CEO09/07/201714,893
TRUEX PAUL FChief Executive Officer09/20/201610,417
Mueller BrianDirector12/23/201528,900
Hislop ColinChief Medical Officer11/13/201520,125
Hislop ColinChief Medical Officer11/13/201566,341
ODINK DEBRAChief Technology Officer10/12/20157,411
TRUEX PAUL FPresident and CEO06/30/20142,370
TRUEX PAUL FPresident and CEO06/30/20144,160
TRUEX PAUL FPresident and CEO06/30/201320,625
TRUEX PAUL FPresident and CEO03/25/201429,614
LIU MAYChief Accounting Officer03/25/20141,746
ODINK DEBRAChief Technology Officer03/25/20149,184
TRUEX PAUL FPresident and CEO03/25/201420,625
TRUEX PAUL FPresident and CEO03/25/201425,153
ODINK DEBRAChief Technology Officer06/30/20131,102
LIU MAYChief Accounting Officer06/30/2013331
Thompson David E.Director06/24/201353,000
DZIURZYNSKI BOGDANDirector05/31/20135,900
ORBIMED ADVISORS LLCDirector01/30/20133,762,000
ORBIMED ADVISORS LLCDirector01/25/20131,142,481
TRUEX PAUL FPresident and CEO01/03/201312,043
KILFOIL GEORGINASVP,Product Dev.& Project Mgmt01/03/20131,663
ODINK DEBRAChief Technology Officer01/03/20132,352
Hislop ColinChief Medical Officer01/03/20133,146
LOWE CHRISTOPHER P.C.F.O. and C.B.O.01/03/20135,975
KILFOIL GEORGINASVP,Product Dev.& Project Mgmt06/30/20121,427
ODINK DEBRAChief Technology Officer06/30/20121,268
ORBIMED ADVISORS LLCDirector06/29/2012942,071
HENNEY CHRISTOPHER SDirector06/29/201274,930
HENNEY CHRISTOPHER SDirector06/29/201274,930
TRUEX PAUL FPresident and CEO06/29/201215,200
ORBIMED ADVISORS LLCDirector03/22/20123,140,131
ORBIMED ADVISORS LLCDirector03/21/2012358,312
ORBIMED ADVISORS LLCDirector03/20/2012338,638
ODINK DEBRAChief Technology Officer03/01/201213,140
Hislop ColinChief Medical Officer02/23/201210,400
TRUEX PAUL FPresident and C.E.O.02/15/2012117,600
Hislop ColinChief Medical Officer02/03/2012246,000
LOWE CHRISTOPHER P.C.F.O. and C.B.O.02/01/2012114,900
ODINK DEBRAChief Technology Officer02/01/201215,340
TRUEX PAUL FPresident and C.E.O.01/31/20125,200
HEALY JAMESDirector01/28/201250,280
TRUEX PAUL FPresident and Chief Executive01/17/2012101,250
ODINK DEBRAChief Technology Officer01/10/20125,205
ODINK DEBRAChief Technology Officer01/06/20127,800
HEALY JAMESDirector12/30/2011155,625
SOFINNOVA VENTURE PARTNERS VI L P10% Owner12/30/2011155,625
HEALY JAMESDirector12/22/2011155,605
HEALY JAMESDirector12/21/2011162,770
SOFINNOVA VENTURE PARTNERS VI L P10% Owner12/22/2011155,605
SOFINNOVA VENTURE PARTNERS VI L P10% Owner12/21/2011162,770
SOFINNOVA VENTURE PARTNERS VI L P10% Owner03/04/20108,462,757
SOFINNOVA VENTURE PARTNERS VI L P10% Owner03/04/20104,097,698
TRUEX PAUL FPresident and CEO12/15/201195,065
ORBIMED ADVISORS LLCDirector12/13/2011105,300
ORBIMED ADVISORS LLCDirector12/09/2011270,000
ORBIMED ADVISORS LLCDirector11/16/2011171,750
ORBIMED ADVISORS LLCDirector11/18/201119,500
ORBIMED ADVISORS LLCDirector11/17/2011160,080
TRUEX PAUL FPresident and CEO11/15/2011208,704
ORBIMED ADVISORS LLCDirector11/11/201135,700
ORBIMED ADVISORS LLCDirector11/15/2011346,500
ORBIMED ADVISORS LLCDirector11/14/201134,750
Hislop ColinChief Medical Officer11/08/20113,900
Hislop ColinChief Medical Officer11/08/2011101,163
LOWE CHRISTOPHER P.Chief Financial Officer & CBO11/03/2011103,236
LOWE CHRISTOPHER P.Chief Financial Officer & CBO10/25/201132,784
TRUEX PAUL FPresident and CEO10/21/2011145,219
TRUEX PAUL FPresident and CEO10/18/201142,156
LOWE CHRISTOPHER P.Chief Financial Officer & CBO08/08/201113,400
TRUEX PAUL FPresident and CEO08/08/201113,000
LOWE CHRISTOPHER P.Chief Financial Officer & CBO08/03/2011100,432
LOWE CHRISTOPHER P.Chief Financial Officer & CBO08/02/201136,571
TRUEX PAUL FPresident and CEO07/15/2011119,258
Hislop ColinChief Medical Officer07/12/20113,900
VANTAGEPOINT VENTURE ASSOCIATES IV LLC10% Owner07/07/201147,264
TRUEX PAUL FPresident and CEO06/30/2011396,245
LOWE CHRISTOPHER P.Chief Financial Officer & CBO06/30/2011191,995
KILFOIL GEORGINASVP, Prod. Dev. & Project Mngm06/30/201145,956
Hislop ColinChief Medical Officer06/30/2011142,975
ODINK DEBRAVP, Pharmaceutical R&D06/30/201129,984
Hislop ColinChief Medical Officer06/29/20112,600
LOWE CHRISTOPHER P.Chief Financial Officer & CBO06/21/201126,200
VANTAGEPOINT VENTURE ASSOCIATES IV LLC10% Owner06/16/201126,877
TRUEX PAUL FPresident and CEO06/15/2011124,539
VANTAGEPOINT VENTURE ASSOCIATES IV LLC10% Owner06/14/20116,158
VANTAGEPOINT VENTURE ASSOCIATES IV LLC10% Owner06/13/201111,440
ORBIMED ADVISORS LLCDirector06/10/2011245,400
ORBIMED ADVISORS LLCDirector06/09/2011300,070
ORBIMED ADVISORS LLCDirector06/08/2011264,660
ORBIMED ADVISORS LLCDirector05/18/2011556,752
ORBIMED ADVISORS LLCDirector05/17/2011832,000
ORBIMED ADVISORS LLCDirector05/16/201186,400
ORBIMED ADVISORS LLCDirector05/11/201193,860
ORBIMED ADVISORS LLCDirector05/10/2011769,272
ORBIMED ADVISORS LLCDirector05/09/201172,600
VANTAGEPOINT VENTURE ASSOCIATES IV LLC10% Owner05/26/201141,280
ORBIMED ADVISORS LLCDirector05/26/2011291,726
ORBIMED ADVISORS LLCDirector05/25/201141,520
VANTAGEPOINT VENTURE ASSOCIATES IV LLC10% Owner05/25/2011283,943
VANTAGEPOINT VENTURE ASSOCIATES IV LLC10% Owner05/24/2011439,490
VANTAGEPOINT VENTURE ASSOCIATES IV LLC10% Owner05/23/2011218,431
VANTAGEPOINT VENTURE ASSOCIATES IV LLC10% Owner05/19/20111,003,750
VANTAGEPOINT VENTURE ASSOCIATES IV LLC10% Owner05/17/2011115,231
TRUEX PAUL FPresident and CEO05/16/2011107,339
ORBIMED ADVISORS LLCDirector05/18/2011556,752
ORBIMED ADVISORS LLCDirector05/17/2011832,000
ORBIMED ADVISORS LLCDirector05/16/201186,400
ORBIMED ADVISORS LLCDirector05/10/2011769,272
ORBIMED ADVISORS LLCDirector05/09/201172,600
ORBIMED ADVISORS LLCDirector05/11/201193,860
VANTAGEPOINT VENTURE ASSOCIATES IV LLC10% Owner05/05/20112,717,777
VANTAGEPOINT VENTURE ASSOCIATES IV LLC10% Owner05/04/20111,400,000
VANTAGEPOINT VENTURE ASSOCIATES IV LLC10% Owner05/03/2011700,000
ODINK DEBRAVP, Pharmaceutical R&D04/13/20115,000
TRUEX PAUL FPresident and CEO04/13/20117,800
Thompson David E.Director01/03/201116,067
ORBIMED ADVISORS LLC10% Owner09/30/201081,192
ODINK DEBRAVP, Pharmaceutical R&D09/24/20104,200
LOWE CHRISTOPHER P.CFO & VP of Administration09/24/201020,900
Leheny A. RachelDirector09/24/2010750,000
Trias JoaquimSr. VP, Preclinical Developmen09/21/20106,614
Hislop ColinSr. VP, Cardiovasc. Prod.09/21/20103,818
Hislop ColinSr. VP, Cardiovasc. Prod.08/18/20102,400
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR ANTHERA PHARMACEUTICALS INC
LOADING...